CANNABINOIDCARBONSÄUREN, SALZE VON CANNABINOIDCARBONSÄUREN, DEREN HERSTELLUNG UND ANWENDUNGEN
    4.
    发明公开
    CANNABINOIDCARBONSÄUREN, SALZE VON CANNABINOIDCARBONSÄUREN, DEREN HERSTELLUNG UND ANWENDUNGEN 审中-公开
    大麻素碳氢酸,大麻素碳氢酸,生产和应用的盐

    公开(公告)号:EP2760444A1

    公开(公告)日:2014-08-06

    申请号:EP12778040.1

    申请日:2012-10-01

    摘要: The invention relates to a compound selected from the group consisting of all stereoisomers and their mixtures of the compounds of general formulas (1)-(4), in which R
    1 is a straight-chained, branched or cyclic hydrocarbon group with up to 12 C-atoms and X
    + is selected from the group consisting of H
    + , NH
    4
    + , mono, di or trivalent metal cations, NH
    4
    + , primary, secondary, tertiary or quaternary organic ammonium ions with up to 48 C-atoms, which can carry even more functional groups, hydrazinium ion (N
    2 H
    5
    + ), hydroxylammonium ion (NH
    3 OH
    + ), guanidinium ion (CN
    3 H
    6
    + ), and organic derivatives of (N
    2 H
    5
    + ), NH
    3 OH
    + , and CN
    3 H
    6
    + , which can carry even more functional groups, and similar. A method is also provided for producing these compounds, comprising the following steps: producing synthetic cannabinoid carboxylic acids in a chemical reaction, or extracting natural cannabinoid carboxylic acids from plant material or cell cultures of
    Cannabis sativa , and adding a suitable inorganic base, a suitable organic base and/or a suitable inorganic or organic salt in a suitable solvent, to the cannabinoid carboxylic acids or cannabinoid carboxylic acid-rich extracts produced in this manner.

    Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
    8.
    发明公开
    Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities 失效
    具有负激素和/或拮抗剂活性的视黄酸类化合物的合成和用途

    公开(公告)号:EP0931786A3

    公开(公告)日:1999-09-01

    申请号:EP98204074.3

    申请日:1996-08-23

    摘要: The invention provides a compound of the formula
    wherein X is S, O, NR' where R' is H or alkyl of 1 to 6 carbons, or X is [C(R 1 ) 2 ] n where R 1 is independently H or alkyl of 1 to 6 carbons, and n is an integer between 0 and 2; R 2 is hydrogen, lower alkyl of 1 to 6 carbons, F, Cl, Br, I, CF 3 , fluoro substituted alkyl of 1 to 6 carbons, OH, SH, alkoxy of 1 to 6 carbons, or alkylthio of 1 to 6 carbons; R 3 is hydrogen, lower alkyl of 1 to 6 carbons or F; m is an integer having the value 0-3; o is an integer having the value 0-3; Y is a phenyl or naphthyl group, or heteroaryl selected from a group consisting of pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl, oxazolyl, imidazolyl and pyrrazolyl, said phenyl and heteroaryl groups being optionally substituted with one or two R 2 groups; A is (CH 2 ) q where q is 0-5, lower branched chain alkyl having 3-6 carbons, cycloalkyl having 3-6 carbons, alkenyl having 2-6 carbons and 1 or 2 double bonds, alkynyl having 2-6 carbons and 1 or 2 triple bonds; B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8 , CONR 9 R 10 , -CH 2 OH, CH 2 OR 11 , CH 2 OCOR 11 , CHO, CH(OR 12 ) 2 , CHOR 13 O, -COR 7 , CR 7 (OR 12 ) 2 , CR 7 OR 13 O, or tri-lower alkylsilyl, where R 7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R 8 is an alkyl group of 1 to 10 carbons or trimethylsilylalkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl or lower alkylphenyl, R 11 is lower alkyl, phenyl or lower alkylphenyl, R 12 is lower alkyl, and R 13 is divalent alkyl radical of 2-5 carbons, and R 14 is (R 15 ) r -phenyl, (R 15 ) r -naphthyl, or (R 15 ) r -heteroaryl where the heteroaryl group has 1 to 3 heteroatoms selected from the group consisting of O, S and N, r is an integer having the values of 0-5, and R 15 is independently H, F, Cl, Br, I, NO 2 , N(R 8 ) 2 , N(R 8 )COR 8 , NR 8 CON(R 8 ) 2 , OH, OCOR 8 , OR 8 , CN, an alkyl group having 1 to 10 carbons, fluoro substituted alkyl group having 1 to 10 carbons, an alkenyl group having 1 to 10 carbons and 1 to 3 double bonds, alkynyl group having 1 to 10 carbons and 1 to 3 triple bonds, or a trialkylsilyl or trialkylsilyloxy group where the alkyl groups independently have 1 to 6 carbons; R 16 is H, lower alkyl of 1 to 6 carbons; R 17 is H, lower alkyl of 1 to 6 carbons, OH or OCOR 11 , and p is zero or 1, with the proviso that when p is 1 then there is no R 17 substituent group, and m is an integer between 0 and 2.

    摘要翻译: 本发明提供下式化合物,其中X是S,O,NR',其中R'是H或1-6个碳原子的烷基,或者X是[C(R1)2] n,其中R1独立地是H或1的烷基 至6个碳,并且n是0至2之间的整数; R2为氢,1-6个碳的低级烷基,F,Cl,Br,I,CF3,1-6个碳的氟取代的烷基,OH,SH,1-6个碳的烷氧基或1-6个碳的烷硫基; R3是氢,1至6个碳的低级烷基或F; m是值为0-3的整数; o是值为0-3的整数; Y是苯基或萘基,或选自吡啶基,噻吩基,呋喃基,哒嗪基,嘧啶基,吡嗪基,噻唑基,恶唑基,咪唑基和吡唑基的杂芳基,所述苯基和杂芳基任选被一个或两个R2基团取代 ; A是(CH 2)q,其中q是0-5,具有3-6个碳的低级支链烷基,具有3-6个碳的环烷基,具有2-6个碳和1或2个双键的烯基,具有2-6个碳的炔基和 1或2个三键; B为氢,COOH或其药学上可接受的盐,COOR8,CONR9R10,-CH2OH,CH2OR11,CH2OCOR11,CHO,CH(OR12)2,CHOR13O,-COR7,CR7(OR12)2,CR7OR13O或三低级烷基甲硅烷基, 其中R7为含有1至5个碳的烷基,环烷基或链烯基,R8为1至10个碳的烷基或三甲基甲硅烷基烷基,其中烷基具有1至10个碳或5至10个碳的环烷基,或R8 为苯基或低级烷基苯基,R9和R10独立地为氢,1-10个碳的烷基或5-10个碳的环烷基,或苯基或低级烷基苯基,R11为低级烷基,苯基或低级烷基苯基,R12为 低级烷基,且R 13为2-5个碳的二价烷基,且R 14为(R 15)r - 苯基,(R 15)r - 萘基或(R 15)r - 杂芳基,其中杂芳基具有1至3个选自 由O,S和N组成的组,r是0-5的整数,并且R 15独立地为H,F,Cl,Br,I,NO 2,N(R 8)2,N(R 8) NR8CON(R8) 2,OH,OCOR 8,OR 8,CN,碳原子数1〜10的烷基,碳原子数1〜10的氟取代烷基,碳原子数1〜10的烯基和1〜3个双键,碳原子数1〜10的炔基 碳原子和1至3个三键,或三烷基甲硅烷基或三烷基甲硅烷氧基,其中烷基独立地具有1至6个碳; R16是H,1至6个碳的低级烷基; R17是H,1至6个碳的低级烷基,OH或OCOR11,并且p是0或1,条件是当p是1时,则不存在R17取代基,并且m是0至2之间的整数。